Advanced Search

Monogenic Stocks List

Symbol Grade Name % Change
SGMO F Sangamo BioSciences, Inc. -3.70
VYGR F Voyager Therapeutics, Inc. -2.29
RYTM F Rhythm Pharmaceuticals, Inc. -4.22
PASG F Passage Bio, Inc. 1.89
TSHA F Taysha Gene Therapies, Inc. 0.00
View As Page of Charts
Related Industries: Biotechnology
Related Stock Lists: Biotechnology Gene Therapy Huntington's Disease Life Sciences Lipid Storage Disorders Medicine Monogenic Diseases Organ Systems Rare Diseases Amyotrophic Lateral Sclerosis Ataxia Biopharmaceutical Blastoma Cell Product Central Nervous System Disorders Deficiency Deficiency Syndrome Dow Agrosciences Emerging Technologies Friedreich's Ataxia

Related ETFs - A few ETFs which own one or more of the above listed Monogenic stocks.

Symbol Grade Name Weight
BBC C Virtus LifeSci Biotech Clinical Trials ETF 2.59
PBE D PowerShares Dynamic Biotech & Genome 2.56
LUXE B Emles Trust Emles Luxury Goods ETF 1.7
GNOM D Global X Genomics & Biotechnology ETF 1.54
XBI D SPDR Series Trust SPDR S&P Biotech ETF 1.28
View all Monogenic related ETFs...
Compare ETFs
  • Compare LUXE to GNOM
  • Compare PBE to LUXE
  • Compare PBE to XBI

    • Recent Signals

    Date Stock Signal Type
    2021-03-03 PASG 20 DMA Resistance Bearish
    2021-03-03 PASG Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-03-03 PASG 200 DMA Resistance Bearish
    2021-03-03 SGMO 200 DMA Resistance Bearish
    2021-03-03 TSHA Stochastic Buy Signal Bullish
    2021-03-03 VYGR Lower Bollinger Band Walk Weakness
    2021-03-03 VYGR New 52 Week Closing Low Bearish
    2021-03-03 VYGR New 52 Week Low Weakness

    Recent News for Monogenic Stocks

    Date Stock Title
    Mar 3 VYGR VOYAGER THERAPEUTICS, INC.  CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Voyager T...
    Mar 3 VYGR VYGR Breaking Notice: Rosen, Top Ranked Investor Counsel, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline - VYGR
    Mar 3 PASG Passage Bio, Inc. (PASG) CEO Bruce Goldsmith on Q4 2020 Results - Earnings Call Transcript
    Mar 3 PASG Passage Bio EPS misses by $0.14
    Mar 3 TSHA Taysha Gene Therapies Reports Full-Year 2020 Financial Results and Provides a Corporate Update
    Mar 3 PASG Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
    Mar 3 PASG Passage Bio Inc to Host Earnings Call
    Mar 3 TSHA Taysha Gene Therapies Inc to Host Earnings Call
    Mar 3 PASG Earnings Scheduled For March 3, 2021
    Mar 2 PASG Passage Bio to Participate in Upcoming March Investor Conferences
    Mar 2 VYGR FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
    Mar 2 TSHA Earnings Scheduled For March 2, 2021
    Mar 1 SGMO Is Sangamo Therapeutics (SGMO) Stock a Buy For 2021?
    Mar 1 RYTM Rhythm Pharmaceuticals reports Q4 results
    Mar 1 RYTM Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
    Mar 1 TSHA Taysha Gene Therapies to Release Full-Year 2020 Financial Results and Host Conference Call and Webcast on March 3
    Feb 28 VYGR Things Look Grim For Voyager Therapeutics, Inc. (NASDAQ:VYGR) After Today's Downgrade
    Feb 27 PASG The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
    Feb 27 VYGR VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline – VYGR
    Feb 26 SGMO Sangamo Therapeutics (SGMO) Presents At SVB Leerink 10th Annual Global Healthcare Conference - Slideshow
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Gene Therapy Huntington's Disease Life Sciences Lipid Storage Disorders Medicine Monogenic Diseases Organ Systems Rare Diseases Amyotrophic Lateral Sclerosis Ataxia Biopharmaceutical Blastoma Cell Product Central Nervous System Disorders Deficiency Deficiency Syndrome Dow Agrosciences Emerging Technologies Friedreich's Ataxia

    Browse All Tags